Charles Schwab holds 7.06% of Medifast (NYSE: MED) common stock
Rhea-AI Filing Summary
Charles Schwab Investment Management Inc. has filed an amended Schedule 13G reporting beneficial ownership of 776,829 shares of Medifast Inc. common stock, representing 7.06% of the outstanding class as of 12/31/2025. Schwab has sole voting and sole dispositive power over these shares.
The shares are held in the ordinary course of business and not with the purpose or effect of changing or influencing control of Medifast. Schwab acts as investment adviser to the Schwab Fundamental U.S. Small Company ETF, which on its own holds 5.12% of Medifast’s common stock.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What percentage of Medifast (MED) does Charles Schwab Investment Management own?
Charles Schwab Investment Management beneficially owns 7.06% of Medifast’s common stock, or 776,829 shares, as of 12/31/2025. This ownership gives Schwab sole voting and dispositive power over those shares, making it a significant institutional shareholder.
Which Schwab fund holds a major stake in Medifast (MED)?
The Schwab Fundamental U.S. Small Company ETF, advised by Charles Schwab Investment Management, holds 5.12% of Medifast’s common stock. This ETF is a registered investment company, and its Medifast position is part of the overall 7.06% stake reported in the filing.
Is Charles Schwab Investment Management seeking control of Medifast (MED)?
Charles Schwab Investment Management states the Medifast shares were acquired and are held in the ordinary course of business. It certifies they are not held for the purpose or effect of changing or influencing control of Medifast or participating in control-related transactions.
What type of SEC filing did Charles Schwab make regarding Medifast (MED)?
Charles Schwab Investment Management filed an amended Schedule 13G for Medifast common stock. This form is used by certain institutional investors to report significant share ownership when the holdings are passive and not intended to influence or change control of the issuer.
On what date is Charles Schwab’s Medifast (MED) ownership information reported?
The ownership information is reported as of December 31, 2025. On that date, Charles Schwab Investment Management’s beneficial holdings in Medifast totaled 776,829 common shares, representing 7.06% of the company’s outstanding common stock according to the filing.